Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
基本信息
- 批准号:10672952
- 负责人:
- 金额:$ 20.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-14 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdministrative CoordinationAdvisory CommitteesAwardCancer CenterChemicalsCommunicationCommunication ProgramsComplexDevelopmentDoctor of PhilosophyEnsureExpenditureFosteringFundingFunding OpportunitiesFutureGoalsGrantGuidelinesHygieneImmunotherapyInstitutionLawsLeadershipMissionMolecular TargetMonitorNational Cancer InstitutePoliciesPrincipal InvestigatorRadiationRadionuclide therapyRegulationReportingResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesSafetyServicesStructureTimeUniversitiesVertebral columnWisconsinanimal careexperienceimmunoregulationmeetingsorganizational structureprogramsresponsetimelinetumorweb site
项目摘要
PROJECT SUMMARY – ADMINISTRATIVE CORE
The Administrative Core (Admin Core) provides the operational structure necessary for the planning,
implementation and management of all P01 activities and promotes the efficient, progressive and successful
conduct consistent with the program goals and P01 mission. It also provides administrative coordination,
oversight and research support services to all leaders, co-leaders, investigators and core directors. By providing
this support centrally, the Admin Core promotes efficiency and ensures that all P01 research and activities are
focused and connected, complex scientific objectives are met, and existing cancer center resources are utilized
and not duplicated. Finally, the Admin Core provides required project oversight, monitoring and auditing to
ensure projects are meeting stated endpoints consistent with the P01 research plan and adhering to all regulatory
requirements. An experienced, half-time administrative associate, Shari Piaskowski, will serve as the
administrative manager of the P01, with support from institutional post award staff from University of Wisconsin
central offices.
项目摘要-行政核心
行政核心(Admin Core)提供规划所需的业务结构,
所有P01活动的实施和管理,并促进高效,渐进和成功的
与项目目标和P01使命一致。它还提供行政协调,
向所有领导人、共同领导人、调查员和核心主任提供监督和研究支助服务。通过提供
通过集中提供这种支持,管理核心提高了效率,并确保所有P01研究和活动都
满足了集中的、相互关联的、复杂的科学目标,并利用了现有的癌症中心资源
而不是复制。最后,管理核心提供所需的项目监督、监控和审计,
确保项目符合与P01研究计划一致的规定终点,并遵守所有法规
要求.一位经验丰富的半职行政助理Shari Piaskowski将担任
P01的行政经理,得到了威斯康星州大学机构职位奖励工作人员的支持
中央办公室。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMEY P WEICHERT其他文献
JAMEY P WEICHERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMEY P WEICHERT', 18)}}的其他基金
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10024889 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10263245 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10416049 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10416045 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10672913 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
用于剂量测定引导免疫调节的新型分子靶向放射性核素疗法
- 批准号:
10024881 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
- 批准号:
10263250 - 财政年份:2020
- 资助金额:
$ 20.31万 - 项目类别:
IMTEK MICROCAT II MICROCT SCANNER: BREAST, PANCREATIC, & THYROID CANCER
IMTEK MICROCAT II 微型 CT 扫描仪:乳房、胰腺、
- 批准号:
7166483 - 财政年份:2005
- 资助金额:
$ 20.31万 - 项目类别:
相似海外基金
Data Resource and Administrative Coordination Center for the Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
精神科和神经发育障碍风险基因联盟的可扩展和系统神经生物学数据资源和行政协调中心
- 批准号:
10642251 - 财政年份:2023
- 资助金额:
$ 20.31万 - 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
- 批准号:
9302796 - 财政年份:2015
- 资助金额:
$ 20.31万 - 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
- 批准号:
8946851 - 财政年份:2015
- 资助金额:
$ 20.31万 - 项目类别:
Scientific Leadership and Administrative Coordination of PPG
PPG的科学领导和行政协调
- 批准号:
8583041 - 财政年份:2013
- 资助金额:
$ 20.31万 - 项目类别:
Scientific and Administrative Coordination Core (SAC CORE)
科学和行政协调核心(SAC CORE)
- 批准号:
8092703 - 财政年份:2010
- 资助金额:
$ 20.31万 - 项目类别:
Scientific and Administrative Coordination Core (SAC CORE)
科学和行政协调核心(SAC CORE)
- 批准号:
7751737 - 财政年份:2009
- 资助金额:
$ 20.31万 - 项目类别: